SCHEMBL4987372

SCHEMBL4987372

O=C(NCCS)C(=O)NCCS

nearest known ligand 0.56

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 14/20 0.56
HDAC6 Q9UBN7 14/20 0.56
HDAC7 Q8WUI4 9/20 0.56
HDAC8 Q9BY41 9/20 0.56
HDAC3 O15379 8/20 0.56
HDAC4 P56524 8/20 0.56
HDAC2 Q92769 8/20 0.56
HDAC10 Q969S8 8/20 0.56
HDAC11 Q96DB2 8/20 0.56
HDAC9 Q9UKV0 8/20 0.56
HDAC5 Q9UQL6 8/20 0.56
FBP1 P09467 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22868164 0.83
SCHEMBL5507236 0.83
SCHEMBL4993796 0.80 FBP1 (0.42) HDAC1HDAC6HDAC7HDAC8HDAC3
SCHEMBL10309086 0.79 HDAC1 (0.42) HDAC1HDAC6HDAC7HDAC8HDAC3
SCHEMBL27877641 0.79 HDAC1 (0.41) HDAC1HDAC6HDAC7HDAC8HDAC3
SCHEMBL151578 0.79
SCHEMBL878213 0.78
SCHEMBL8906627 0.78 HDAC3 (0.57) HDAC1HDAC6HDAC7HDAC8HDAC3
SCHEMBL19522561 0.77 HDAC1 (0.40) HDAC1HDAC6HDAC7HDAC8HDAC3
SCHEMBL929676 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080138309-A1 Use Of Aminodithiol As A Reducing Agent For Hair Perming L'OREAL S.A. (FR) 2008-06-12 US claimed
EP-0135160-B1 BISAMIDE BISTHIOL COMPOUNDS USEFUL FOR MAKING TECHNETIUM RADIODIAGNOSTIC RENAL AGENTS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1989-04-26 EP claimed
EP-0135160-A2 Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1985-03-27 EP claimed
WO-2023165987-A1 PRECURSOR MARKERS AND RADIOTRACERS WITH THREE OR MORE TARGETING VECTORS FOR THERANOSTICS USED IN NUCLEAR MEDICINE Atoms for Cure GmbH (DE) 2023-09-07 WO disclosed
US-20230211599-A1 Lithographic Photopolymer Printing Plate Precursor with Improved Daylight Stability AGFA OFFSET BV (BE) 2023-07-06 US disclosed
US-20230211599-A1 Lithographic Photopolymer Printing Plate Precursor with Improved Daylight Stability AGFA OFFSET BV (BE) 2023-07-06 US disclosed
WO-2023118195-A1 FAP-TARGETING PHARMACEUTICAL PRODUCT FOR THERAPY AND DIAGNOSIS OF CANCERS Atoms for Cure GmbH (DE) 2023-06-29 WO disclosed
WO-2022258637-A1 TRISLINKER-CONJUGATED DIMERIC LABELLING PRECURSORS AND RADIOTRACERS DERIVED THEREFROM Atoms for Cure GmbH (DE) 2022-12-15 WO disclosed
WO-2021249754-A1 LITHOGRAPHIC PHOTOPOLYMER PRINTING PLATE PRECURSOR WITH IMPROVED DAYLIGHT STABILITY AGFA OFFSET BV (BE) 2021-12-16 WO disclosed
EP-3922462-A1 LITHOGRAPHIC PHOTOPOLYMER PRINTING PLATE PRECURSOR WITH IMPROVED DAYLIGHT STABILITY AGFA OFFSET BV (BE) 2021-12-15 EP disclosed
US-9482954-B2 Lithographic printing plate precursor AGFA GRAPHICS NV (BE) 2016-11-01 US disclosed
WO-2014198823-A1 A LITHOGRAPHIC PRINTING PLATE PRECURSOR AGFA GRAPHICS NV (BE) 2014-12-18 WO disclosed
US-8551447-B2 Bifunctional compound with monosaccharide and N2S2 ligand, and preparation and use thereof INSTITUTE OF NUCLEAR ENERGY RESEARCH ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN (TW) 2013-10-08 US disclosed
US-8551447-B2 Bifunctional compound with monosaccharide and N2S2 ligand, and preparation and use thereof INSTITUTE OF NUCLEAR ENERGY RESEARCH ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN (TW) 2013-10-08 US disclosed
US-20120009669-A1 BIFUNCTIONAL COMPOUND WITH MONOSACCHARIDE AND N2S2 LIGAND, AND PREPARATION AND USE THEREOF INSTITUTE OF NUCLEAR ENERGY RESEARCH ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN (TW) 2012-01-12 US disclosed
US-20120009669-A1 BIFUNCTIONAL COMPOUND WITH MONOSACCHARIDE AND N2S2 LIGAND, AND PREPARATION AND USE THEREOF INSTITUTE OF NUCLEAR ENERGY RESEARCH ATOMIC ENERGY COUNCIL, EXECUTIVE YUAN (TW) 2012-01-12 US disclosed
US-20080138309-A1 Use Of Aminodithiol As A Reducing Agent For Hair Perming L'OREAL S.A. (FR) 2008-06-12 US disclosed
EP-0135160-B1 BISAMIDE BISTHIOL COMPOUNDS USEFUL FOR MAKING TECHNETIUM RADIODIAGNOSTIC RENAL AGENTS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1989-04-26 EP disclosed
US-4673562-A Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 1987-06-16 US disclosed
EP-0135160-A2 Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1985-03-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080138309-A1 Use Of Aminodithiol As A Reducing Agent For Hair Perming AASDHPPT, BHMT2, ALAD HDAC1 2576/4885HDAC6 2970/4885HDAC7 2641/4885
US-20120009669-A1 BIFUNCTIONAL COMPOUND WITH MONOSACCHARIDE AND N2S2 LIGAND, AND PREPARATION AND USE THEREOF B3GNT2, FUT5, FUT6 HDAC1 533/4885HDAC6 1764/4885HDAC7 1371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.